AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARalpha and PGC-1. - Wikidata - awgldk - TriplyDB

AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARalpha and PGC-1.

AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARalpha and PGC-1.

http://www.wikidata.org/entity/Q34477777

about

Apolipoprotein O is mitochondrial and promotes lipotoxicity in heart Getting 'Smad' about obesity and diabetes Skeletal muscle-selective knockout of LKB1 increases insulin sensitivity, improves glucose homeostasis, and decreases TRB3 Hydroxycinnamic acid derivatives: a potential class of natural compounds for the management of lipid metabolism and obesity PPARs: Protectors or Opponents of Myocardial Function?AMPK as a potential anticancer target - friend or foe?Effects of fatty acid treatments on the dexamethasone-induced intramuscular lipid accumulation in chickens Insights into the molecular mechanisms of the anti-atherogenic actions of flavonoids in normal and obese mice Leptin administration favors muscle mass accretion by decreasing FoxO3a and increasing PGC-1alpha in ob/ob mice Bezafibrate administration improves behavioral deficits and tau pathology in P301S mice Mitochondrial stress signaling promotes cellular adaptations AMP-activated protein kinase plays an important evolutionary conserved role in the regulation of glucose metabolism in fish skeletal muscle cells Rho-kinase inhibition ameliorates metabolic disorders through activation of AMPK pathway in mice AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha AMP-activated Protein Kinase (AMPK) Signaling AMP-activated protein kinase-regulated activation of the PGC-1alpha promoter in skeletal muscle cells.Proteome analysis of fatty liver in feed-deprived dairy cows reveals interaction of fuel sensing, calcium, fatty acid, and glycogen metabolism.AMPK enhances the expression of pancreatic duodenal homeobox-1 via PPARalpha, but not PPARgamma, in rat insulinoma cell line INS-1 The dual PPARα/γ agonist aleglitazar increases the number and function of endothelial progenitor cells: implications for vascular function and atherogenesis.Mitochondrial metabolism and diabetes Effects of epigallocatechin-3-gallate on thermogenesis and mitochondrial biogenesis in brown adipose tissues of diet-induced obese mice.Abnormal n-6 fatty acid metabolism in cystic fibrosis is caused by activation of AMP-activated protein kinase Anti-obesity effects of Lysimachia foenum-graecum characterized by decreased adipogenesis and regulated lipid metabolism.Identification of recently selected mutations driven by artificial selection in hanwoo (korean cattle).Signaling mechanisms in skeletal muscle: acute responses and chronic adaptations to exercise.Targeted therapies of the LKB1/AMPK pathway for the treatment of insulin resistance Caffeine attenuates lipid accumulation via activation of AMP-activated protein kinase signaling pathway in HepG2 cells.The muscle fiber type-fiber size paradox: hypertrophy or oxidative metabolism?Abnormal unsaturated fatty acid metabolism in cystic fibrosis: biochemical mechanisms and clinical implications.The PGC-1 cascade as a therapeutic target for heart failure Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity.AICAR inhibits adipocyte differentiation in 3T3L1 and restores metabolic alterations in diet-induced obesity mice model Toll-like receptor-mediated inflammatory signaling reprograms cardiac energy metabolism by repressing peroxisome proliferator-activated receptor γ coactivator-1 signaling.Yhhu981, a novel compound, stimulates fatty acid oxidation via the activation of AMPK and ameliorates lipid metabolism disorder in ob/ob mice.Role of the AMPK/SREBP-1 pathway in the development of orotic acid-induced fatty liver.Artemisinin mimics calorie restriction to trigger mitochondrial biogenesis and compromise telomere shortening in mice AMP-activated protein kinase controls exercise training- and AICAR-induced increases in SIRT3 and MnSOD PPARα Protein Expression Was Increased by Four Weeks of Intermittent Hypoxic Training via AMPKα2-Dependent Manner in Mouse Skeletal Muscle Deficiency for costimulatory receptor 4-1BB protects against obesity-induced inflammation and metabolic disorders 5-Aminoimidazole-4-carboxyamide-ribonucleoside (AICAR)-stimulated hepatic expression of Cyp4a10, Cyp4a14, Cyp4a31, and other peroxisome proliferator-activated receptor α-responsive mouse genes is AICAR 5'-monophosphate-dependent and AMP-activated pr

P2860

Q24294870-ECA08D9B-6F2C-47A4-A65B-F22A6D78C374 Q24630117-213347EE-2D22-4E0C-AE69-6B3595B8EB9A Q24672153-1BE3704A-442E-47EA-BFEC-4C645E0B9B20 Q26749072-568D775A-5923-4645-8F07-A0D9FC500782 Q26771753-5F715496-C738-4E6F-8B09-0FF7B028F138 Q26829427-575CDAA8-8408-4C8B-B14C-5E0F2DE9D235 Q27303384-D97E18A8-1241-44D7-B737-447F9F8AD48F Q27320899-085D4816-D9DB-4C2C-8F68-586048C62040 Q27342830-821DEF0E-B2FB-40E4-93CB-9592AE3FB4E6 Q28273620-AE94E434-6F83-4998-A0F2-37B4A61FA5CB Q28395762-8BE5810A-41E7-41C2-A9CF-C82A2AD7B789 Q28480896-CDFC0EF2-97C3-44AA-AC49-2D671FCE7027 Q28544668-69DF044D-7BC4-49CA-B635-494046253EA8 Q29620443-3E1305B0-1A3B-4259-BA7D-42DB47B01FED Q30102296-E6C7C2E2-4499-433A-90B8-4737A6942BAB Q33381651-2FDDDACC-F3A5-45C5-93E8-38135D259DC2 Q33412067-CD71444C-1BC0-4BFE-ADF1-503DA5C36ADD Q33557858-6EF5E11B-F885-4ED1-9B62-A04E62D84FE7 Q33562214-A28717A0-D69A-4D30-9396-CB5B000FF06E Q33609715-D8074E0A-BC5B-498C-857E-B8E3E3C54E61 Q33811006-2E3C9320-EBCF-42B5-A388-E718D2B238BC Q33825143-C2F18EC8-DDB8-4C74-BA2F-7143798090C7 Q33841823-76D7CCDC-9ECF-4375-A081-6D86BCB92F25 Q33885594-2DE3306E-887D-407B-8AF4-69A28A98BBDF Q33913651-15D00CFF-02D2-47AB-AC1D-9A91441FA8C8 Q34004470-2B84B025-B564-4A64-85D8-09E34F4C587F Q34049446-06B9EFCF-BE6F-4461-9198-98F5E8BF77AA Q34213640-A57C9A0F-CCFC-4BD5-9F95-73C6523416D6 Q34358489-32153B12-ED8B-4C01-B113-D31E3CA98597 Q34587748-B512E7C8-3297-49ED-B7D1-2357103ED0B7 Q34603754-32D856A7-3AB3-4F48-9F0B-CBA4C0E5FF5E Q35024638-ABA41126-2D40-43C8-A55E-E1ADB032BF80 Q35129034-158481AF-39B1-4D62-8189-393527770DCD Q35148203-CE7022FF-FC08-46D0-B57B-630BABE2AA7A Q35152192-DAEBE2A6-71B5-4F48-8832-FAC387BDE97A Q35174225-FF55BC09-9FA7-47CF-BFCB-8B8BBDB622FE Q35211876-626FF2FC-A2B6-41B2-A4BE-752677EE5DB2 Q35553487-E50D6E5D-DEF5-4F9F-9420-8117A8C966C4 Q35561102-15FA85F6-2A10-419D-94EA-BD7CED31CE57 Q35579490-7FFFC698-99AD-4A25-8C49-7348848B7CFE

P2860

AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARalpha and PGC-1.

http://www.wikidata.org/entity/Q34477777

description

2005 nî lūn-bûn

@nan

2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

AMPK activation increases fatt ...... ctivating PPARalpha and PGC-1.

@ast

AMPK activation increases fatt ...... ctivating PPARalpha and PGC-1.

@en

AMPK activation increases fatt ...... ctivating PPARalpha and PGC-1.

@nl

type

label

AMPK activation increases fatt ...... ctivating PPARalpha and PGC-1.

@ast

AMPK activation increases fatt ...... ctivating PPARalpha and PGC-1.

@en

AMPK activation increases fatt ...... ctivating PPARalpha and PGC-1.

@nl

prefLabel

AMPK activation increases fatt ...... ctivating PPARalpha and PGC-1.

@ast

AMPK activation increases fatt ...... ctivating PPARalpha and PGC-1.

@en

AMPK activation increases fatt ...... ctivating PPARalpha and PGC-1.

@nl

P1433

Q34477777-904AF215-3FEB-4C86-A316-83851637EF35

P1476

Q34477777-5DDE8C16-552A-46BC-95B2-7DF4CAF22ABA

P2093

Q34477777-046F091A-BD70-4E8F-B6E1-0F91FFE1FDF6

Q34477777-3FB85923-163C-4073-A1CB-EBD2BEE37DF1

Q34477777-44E40F01-8CE7-4B02-9061-962C8726EA44

Q34477777-57FDEB7A-FDC8-4C5F-BBAD-FED25000F016

Q34477777-5ED9E257-0BF1-4285-A705-878B37C0CD90

Q34477777-6883E98E-3434-4F80-BA5F-4CA411897835

Q34477777-6B9F9881-9599-40B8-BD6E-4835B206566E

Q34477777-A33F5819-B14A-4B6F-96AA-7D93849B3A86

Q34477777-CF758E92-AE11-49C8-B2E3-301AEAB4C18C

Q34477777-D581C174-DD52-42E8-814E-1164CE177ABA

P304

Q34477777-C8B2A865-884D-4349-B049-0D283B568485

P31

Q34477777-0A4D5F06-871C-4863-AF64-4B471F77F26D

P356

Q34477777-1601889C-9859-4473-9EDE-CFBD5E7D9689

P407

Q34477777-F648D378-6121-4FB4-A245-43F2A1A85D2F

P433

Q34477777-718A82C4-9858-46CB-9872-D0D79E662BA1

P478

Q34477777-E53FD275-062D-4FE5-9DB0-16995865879F

P577

Q34477777-2FBC538F-FB19-45D9-A21F-1B17E2A4562E

P698

Q34477777-B76792B8-5423-46F7-B466-682F6816828A

P921

Q34477777-7604D406-231B-4F25-B886-A1B517D15B8A

P356

J.BBRC.2005.12.011

P1433

Biochemical and Biophysical Research Communications

P1476

AMPK activation increases fatt ...... ctivating PPARalpha and PGC-1.

@en

P2093

Eun Hee Koh

http://www.w3.org/2001/XMLSchema#string

Goo Taeg Oh

http://www.w3.org/2001/XMLSchema#string

Hye-Sun Park

http://www.w3.org/2001/XMLSchema#string

Hyoun Sik Kim

http://www.w3.org/2001/XMLSchema#string

Jong Chul Won

http://www.w3.org/2001/XMLSchema#string

Joong-Yeol Park

http://www.w3.org/2001/XMLSchema#string

Ki Sook Oh

http://www.w3.org/2001/XMLSchema#string

Ki-Up Lee

http://www.w3.org/2001/XMLSchema#string

Michung Yoon

http://www.w3.org/2001/XMLSchema#string

Min Jae Jeon

http://www.w3.org/2001/XMLSchema#string

P304

291-295

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBRC.2005.12.011

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

340

http://www.w3.org/2001/XMLSchema#string

P577

2005-12-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16364253

http://www.w3.org/2001/XMLSchema#string

P921